Amber Emery Esparza
Medical · Carmichael, CANPI 1710136833
Payments from drug & device makers
Across 85 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$343
- GSK$146
- Novo Nordisk$145
- Collegium Pharmaceutical, Inc.$143
- Exact Sciences$138
- Pfizer$127
- plus $804 from 19 others
What the payments were for
- Speaking & faculty fees$1005%
- Food & beverage$1,73494%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $343 |
| GSK | 7 | $146 |
| Novo Nordisk | 7 | $145 |
| Collegium Pharmaceutical, Inc. | 8 | $143 |
| Exact Sciences | 6 | $138 |
| Pfizer | 5 | $127 |
| Mckesson Medical-surgical, Inc. | 1 | $100 |
| AbbVie | 4 | $86 |
| Abbott | 1 | $72 |
| Boehringer Ingelheim | 4 | $69 |
| Amgen | 3 | $63 |
| Scilex Pharmaceuticals Inc. | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Merck | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| IBSA Pharma Inc. | 2 | $37 |
| Fidia Pharma USA Inc. | 1 | $28 |
| Nestle Healthcare Nutrition Inc. | 1 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Gilead | 1 | $20 |
| Almatica Pharma LLC | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
How this compares
$1,846 in reported general payments places this provider in the 70th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $78,333 |
| EliquisApixaban | 35 | $33,352 |
| TrulicityDulaglutide | 21 | $22,349 |
| Xtampza ErOxycodone Myristate | 12 | $21,449 |
| BelsomraSuvorexant | 21 | $10,149 |
| BelbucaBuprenorphine Hcl | 12 | $10,099 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 289 | $7,907 |
| ButransBuprenorphine | 12 | $6,163 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,241 |
| Buprenorphine | 19 | $4,490 |
| Lidocaine | 19 | $3,143 |
| Testosterone | 28 | $2,333 |
| Atorvastatin Calcium | 90 | $1,635 |
| Gabapentin | 110 | $1,487 |
| Ventolin HfaAlbuterol Sulfate | 24 | $1,437 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $145 | $78,33354 claims |
| PfizerEliquis | $127 | $33,35235 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $143 | $31,54924 claims |
| Lilly USA, LLCTrulicity | $343 | $22,34921 claims |
| MerckBelsomra | $43 | $10,14921 claims |
| GSKBreo Ellipta | $146 | $5,24113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,087 medical providers in California.
Other medical in Carmichael
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.